Drug Innovation At Risk By Trump Budget, Says Congressional Budget Office
The CBO says Trump’s proposed NIH funding cuts and longer FDA review times could significantly reduce the number of new drugs entering the U.S. market. read more
The CBO says Trump’s proposed NIH funding cuts and longer FDA review times could significantly reduce the number of new drugs entering the U.S. market. read more
Ether Machine CEO Andrew Keys on Monday discussed Ethereum’s (CRYPTO: read more
Micron Technology (NASDAQ: MU) launched high-density SLC NAND chip for space, targeting AI-enabled edge computing and expanding in booming space economy. read more
As Tesla is set to announce Q2 results on Wednesday, a herd of ETFs with high concentrations in the EV titan is already revving up. read more
RTX Corp. (NYSE: RTX) shares drop despite beating Q2 2025 expectations and raising full-year forecast with record backlog and dividend increase. read more